Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra hircus and Its Admixtures with Melon Oil for the Delivery of Indomethacin

Table 4

Absolute drug contents of indomethacin-loaded SNEDDS.

Batch*	Ratio of oil blend : surfactant blend : cosurfactant	Absolute drug contents (mg)** ± SD
1A	20 : 60 : 20	15.34±0.96
1B	20 : 60 : 20	16.60±1.28
1C	20 : 60 : 20	16.70±1.09
1D	20 : 60 : 20	19.36±1.83
2A	35 : 45 : 20	15.18±1.07
2B	35 : 45 : 20	17.40±0.84
2C	35 : 45 : 20	18.10±0.53
2D	35 : 45 : 20	19.05±1.91
3A	25 : 55 : 20	17.30±0.82
3B	25 : 55 : 20	18.50±1.65
3C	25 : 55 : 20	15.47±1.26
3D	25 : 55 : 20	19.60±0.99
4A	25 : 60 : 15	18.10±0.74
4B	25 : 60 : 15	19.60±1.58
4C	25 : 60 : 15	19.30±1.92
4D	25 : 60 : 15	18.41±1.87

∗A contains goat fat, B contains goat fat and carbosil, C contains goat fat with melon oil, and D contains goat fat with melon oil and carbosil. **All batches were intended to deliver 20 mg of indomethacin.